Copyright © 2000 by the European Society of Cardiology.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Editorial
Hotline Editorial
Cardiolgy Division, San Francisco General Hospital, San Francisco, California, U.S.A.
References
- Roberts WC. Qualitative and quantitative comparison of amounts of narrowing by atherosclerotic plaques in the major epicardial coronary arteries at necroscopy in sudden coronary death, transmural acute myocardial infarction, transmural healed myocardial infarction and unstable angina pectoris. Am J Cardiol. 1989;64:324328[CrossRef][ISI][Medline]
- Arnett EN, Isner JM, Redwood DR. Coronary artery narrowing in coronary heart disease: comparison of cineangiographic and necroscopy findings. Ann Int Med. 1979;91:350356[ISI][Medline]
- Mintz GS, Painter JA, Pichard AD. Atherosclerosis in angiographically normal coronary artery reference segments: an intravascular ultrasound study with clinical correlations. J Am Coll Cardiol. 1995;25:14791485[Abstract]
- Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995;92:657671
[Free Full Text] - Ravnskov U. Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome. BMJ. 1992;305:1519[ISI][Medline]
- Lancet. 1994;344:13831389[CrossRef][ISI][Medline]
- Sacks FM, Pfeffer MA, Moye LA. N Engl J Med. 1996;335:10011009
[Abstract/Free Full Text] - N Engl J Med. 1998;339:13491357
[Abstract/Free Full Text] - Shepherd J, Cobbe SM, Ford I. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;333:13011307
[Abstract/Free Full Text] - Downs JR, Clearfield M, Weis S. for the AFCAPS/TexCAPS Research Group. JAMA. 1998;279:16151622
[Abstract/Free Full Text] - Waters D. Plaque stabilization: a mechanism for the beneficial effect of lipid-lowering therapies in angiographic studies. Prog Cardiovasc Dis. 1994;37:107120[CrossRef][ISI][Medline]
- Gould KL, Martucci JP, Goldberg DI. Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium. Circulation. 1994;89:15301538
[Abstract/Free Full Text] - Andrews TC, Raby K, Barry J. Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease. Circulation. 1997;95:324328
[Abstract/Free Full Text] - Pitt B, Waters D, Brown WV. N Engl J Med. 1999;341:7076
[Abstract/Free Full Text]
This article has been cited by other articles:
![]() |
L. G. Futterman and L. Lemberg Seminal Changes in the Management of the Acute Coronary Event: Current Concepts Am. J. Crit. Care., January 1, 2003; 12(1): 73 - 76. [Full Text] [PDF] |
||||
![]() |
D.P. Mikhaildis, A.S. Wierzbicki, and T.M. Reynolds Is a mechanical or a metabolic approach superior in the treatment of coronary disease? Results of the atorvastatin versus revascularization (AVERT) trial Eur. Heart J., June 1, 2001; 22(11): 972 - 972. [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

